Ken Griffin’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-231,696
Closed -$11.8M 15964
2024
Q4
$11.8M Buy
231,696
+60,939
+36% +$3M ﹤0.01% 2772
2024
Q3
$7.04M Buy
+170,757
New +$8.2M ﹤0.01% 3423
2023
Q4
Sell
-3,928
Closed -$237K 15453
2023
Q3
$257K Sell
3,928
-187,326
-98% -$11.8M ﹤0.01% 9447
2023
Q2
$11.1M Sell
191,254
-112,682
-37% -$7.11M ﹤0.01% 2535
2023
Q1
$18.8M Sell
303,936
-465,633
-61% -$27.9M ﹤0.01% 1986
2022
Q4
$48.9M Buy
769,569
+739,462
+2,456% +$53.6M 0.01% 1137
2022
Q3
$2.19M Buy
30,107
+24,507
+438% +$1.82M ﹤0.01% 5422
2022
Q2
$381K Sell
5,600
-71,077
-93% -$5.11M ﹤0.01% 9252
2022
Q1
$6.95M Buy
+76,677
New +$6.28M ﹤0.01% 3563
2021
Q4
Sell
-32,544
Closed -$2.79M 14966
2021
Q3
$2.64M Sell
32,544
-957,454
-97% -$80.4M ﹤0.01% 5666
2021
Q2
$92.3M Buy
989,998
+680,072
+219% +$65.9M 0.02% 718
2021
Q1
$33.2M Buy
309,926
+160,086
+107% +$16.6M 0.01% 1422
2020
Q4
$13.1M Buy
149,840
+129,916
+652% +$9.18M ﹤0.01% 2299
2020
Q3
$1.38M Buy
+19,924
New +$1.28M ﹤0.01% 5428

Other funds holding NARI

Ken Griffin's NARI Position: Q1 2025 in Review

Ken Griffin sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 231,696 shares — an estimated $11.8M sold.

Ken Griffin first reported a position in NARI in Q3 2020 and held it in 14 quarters. The position peaked at $92.3M in Q2 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Ken Griffin reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Ken Griffin sold 231,696 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $11.8M.
  • Ken Griffin first reported a position in Inari Medical, Inc. Common Stock in Q3 2020 and held it in 14 quarters.
  • Ken Griffin's Inari Medical, Inc. Common Stock position peaked at $92.3M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.